Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.

View / Open Files

Published version (PDF, 375Kb)

Authors

  Andres-Ejarque, Rosa

Ale, Hira Bahadur

Grys, Katarzyna

Tosi, Isabella

Solanky, Shane

Ainali, Chrysanthi

Catak, Zeynep

Sreeneebus, Hemawtee

  Saklatvala, Jake

  Dand, Nick

de Rinaldis, Emanuele

Chapman, Anna

Nestle, Frank O

  Barnes, Michael R

Warren, Richard B

Reynolds, Nick J

Griffiths, Christopher E M

Barker, Jonathan N

Smith, Catherine H

  Di Meglio, Paola

Show moreShow less

Publication Date

2021-12-16

Journal Title

Nature communications

ISSN

2041-1723

Volume

12

Issue

1

Language

eng

Type

Other

This Version

VoR

Metadata

Show full item record

Citation

Andres-Ejarque, R., Ale, H. B., Grys, K., Tosi, I., Solanky, S., Ainali, C., Catak, Z., et al. (2021). Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.. [Other]. https://doi.org/10.1038/s41467-021-27447-6

Identifiers

34916493, PMC8677717

External DOI: https://doi.org/10.1038/s41467-021-27447-6

This record's DOI: https://doi.org/10.17863/CAM.80746

Rights

Attribution 4.0 International

Licence URL: https://creativecommons.org/licenses/by/4.0/

Statistics



?

Total file downloads (since January 2020). For more information on metrics see the IRUS guide.